The Economic Times
English EditionEnglish Editionहिन्दी
| E-Paper
Search
+

Ivermectin is India’s new hydroxychloroquine against Covid-19

Ivermectin is India’s new hydroxychloroquine against Covid-19
Ivermectin is India’s new hydroxychloroquine against Covid-19

Synopsis

Ivermectin is now in a position where hydroxychloroquine (HCQ) was earlier. Doctors have started prescribing it widely even though there is no concrete evidence about its benefits.

NEW DELHI: World over, and in India, medicine is learning on the job how to fight Covid. And contradictory guidelines or confusion are not uncommon. So it is that although the Indian Council of Medical Research (ICMR) does not recommend anti-parasitic drug ivermectin in its Covid treatment protocol, it is the new favourite for many doctors.Ivermectin is now in a position where hydroxychloroquine (HCQ) was earlier. Doctors have started
Share This Article
  • GIFT ARTICLE
  • FONT SIZE
  • SAVE
  • COMMENT

To Read the Full Story, Become an ET Prime Member

Sign in to read the full article

You’ve got this Prime Story as a Free Gift

Access the exclusive Economic Times stories, Editorial and Expert opinion

Why ?

  • Sharp Insight-rich, Indepth stories across 20+ sectors

  • Access the exclusive Economic Times stories, Editorial and Expert opinion

  • Clean experience with
    Minimal Ads
  • Comment & Engage with ET Prime community
  • Exclusive invites to Virtual Events with Industry Leaders
  • A trusted team of Journalists & Analysts who can best filter signal from noise
The Economic Times